262 related articles for article (PubMed ID: 29404474)
1. Transforming growth factor-β in liver cancer stem cells and regeneration.
Rao S; Zaidi S; Banerjee J; Jogunoori W; Sebastian R; Mishra B; Nguyen BN; Wu RC; White J; Deng C; Amdur R; Li S; Mishra L
Hepatol Commun; 2017 Aug; 1(6):477-493. PubMed ID: 29404474
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.
Majumdar A; Curley SA; Wu X; Brown P; Hwang JP; Shetty K; Yao ZX; He AR; Li S; Katz L; Farci P; Mishra L
Nat Rev Gastroenterol Hepatol; 2012 Sep; 9(9):530-8. PubMed ID: 22710573
[TBL] [Abstract][Full Text] [Related]
3. IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition
Mitra A; Yan J; Xia X; Zhou S; Chen J; Mishra L; Li S
Hepatology; 2017 Apr; 65(4):1222-1236. PubMed ID: 27863449
[TBL] [Abstract][Full Text] [Related]
4. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
[TBL] [Abstract][Full Text] [Related]
5. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
6. TGF-β signaling in liver and gastrointestinal cancers.
Katz LH; Likhter M; Jogunoori W; Belkin M; Ohshiro K; Mishra L
Cancer Lett; 2016 Sep; 379(2):166-72. PubMed ID: 27039259
[TBL] [Abstract][Full Text] [Related]
7. TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy.
Arrese M; Hernandez A; Astete L; Estrada L; Cabello-Verrugio C; Cabrera D
Curr Protein Pept Sci; 2018; 19(12):1172-1179. PubMed ID: 29150921
[TBL] [Abstract][Full Text] [Related]
8. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.
Rojas A; Zhang P; Wang Y; Foo WC; Muñoz NM; Xiao L; Wang J; Gores GJ; Hung MC; Blechacz B
Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.
Wittmann P; Grubinger M; Gröger C; Huber H; Sieghart W; Peck-Radosavljevic M; Mikulits W
BMC Cancer; 2015 Nov; 15():909. PubMed ID: 26573807
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
11. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
12. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
Dooley S; Weng H; Mertens PR
Dig Dis; 2009; 27(2):93-101. PubMed ID: 19546546
[TBL] [Abstract][Full Text] [Related]
13. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
Vilchez V; Turcios L; Marti F; Gedaly R
World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743
[TBL] [Abstract][Full Text] [Related]
15. Liver stem cells and molecular signaling pathways in hepatocellular carcinoma.
Kitisin K; Pishvaian MJ; Johnson LB; Mishra L
Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S13-21. PubMed ID: 19360142
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
17. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers.
Lv X; Xu G
World J Gastrointest Oncol; 2021 Nov; 13(11):1648-1667. PubMed ID: 34853641
[TBL] [Abstract][Full Text] [Related]
18. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
[TBL] [Abstract][Full Text] [Related]
20. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β-catenin and TGF-β/EMT signaling pathways.
Liu Z; Zhang Y; Xu Z
J BUON; 2018; 23(1):185-187. PubMed ID: 29552781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]